A catecholamine-secreting tumour
Cardiomyopathy - A catecholamine-secreting tumour Factor
Last reviewed for CCPS 18 July 2007.
Preliminary questions [38180]
38181 there is some evidence that a catecholamine-secreting tumour may be a factor in the development or worsening of the condition under consideration.
38182 the veteran has had a catecholamine-secreting tumour at some time.
38183 — a catecholamine-secreting tumour is a rare tumour that secretes catecholamine such as a phaeochromocytoma or paraganglioma.
38186 — the veteran has established the causal connection between a catecholamine-secreting tumour and VEA service for cardiomyopathy.
38184 the veteran had the identified illness or injury, a catecholamine-secreting tumour, at the time of the clinical onset of the condition under consideration.
38187 — the veteran has established the causal connection between a catecholamine-secreting tumour and VEA service for the clinical onset of cardiomyopathy.
38189 — the veteran has established the causal connection between a catecholamine-secreting tumour and operational service for the clinical onset of cardiomyopathy.
or
38190 — the veteran has established the causal connection between a catecholamine-secreting tumour and eligible service for the clinical onset of cardiomyopathy.
or
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened. the veteran had the identified illness or injury, a catecholamine-secreting tumour, at the time of the clinical worsening of the condition under consideration.38188 — the veteran has established the causal connection between a catecholamine-secreting tumour and VEA service for the clinical worsening of cardiomyopathy.
38191 — the veteran has established the causal connection between a catecholamine-secreting tumour and operational service for the clinical worsening of cardiomyopathy.
or
38192 — the veteran has established the causal connection between a catecholamine-secreting tumour and eligible service for the clinical worsening of cardiomyopathy.
Clinical onset and operational service [38189]
38193 — the identified illness or injury, a catecholamine-secreting tumour, is causally related to operational service.
Clinical onset and eligible service [38190]
38194 — the identified illness or injury, a catecholamine-secreting tumour, is causally related to eligible service.
Clinical worsening and operational service [38191]
38193 — the identified illness or injury, a catecholamine-secreting tumour, is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, a catecholamine-secreting tumour, is causally related.Clinical worsening and eligible service [38192]
38194 — the identified illness or injury, a catecholamine-secreting tumour, is causally related to eligible service.
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, a catecholamine-secreting tumour, is causally related.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/c-d/cardiomyopathy-g021-4254-425964866748/rulebase-cardiomyopathy/catecholamine-secreting-tumour